Skip to content

Comparison between effect of half and one micrograms per kilograms of intra-nasal Dexmedetomidine as premedication on calmness and agitation score among children one to four years old candidate for cochlear implantation

Comparison between effect of half and one micrograms per kilograms of intra-nasal Dexmedetomidine as premedication on calmness and agitation score among children one to four years old candidate for cochlear implantation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250505065605N1
Enrollment
31
Registered
2025-05-29
Start date
2025-05-31
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Cochlear Implant. Condition 2: Separation anxiety disorder of childhood. Condition 3: Restlessness and agitation. Cochlear implant status Separation anxiety disorder of childhood Restlessness and agitation

Interventions

Intervention 1: Intervention group 1: First, the patient is admitted to the operating room. At least half an hour before the start of the operation, before receiving the anesthetic, he first receives

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Age between 1 to 18 years old Parental Accordance to participate in the research

Exclusion criteria

Exclusion criteria: Asthma Sleep apnea Known Dexmedetomidine-Propofol Allergy

Design outcomes

Primary

MeasureTime frame
Sedation score. Timepoint: Prior to medication consumption, 25 minutes after medication usage. Method of measurement: sedation score.;Agitation score (from 0 to 6). Timepoint: After extubation, Every 10 minutes until Discharge from recovery room. Method of measurement: emergence agitation scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMatin Esnaashari

Esfahan University of Medical Sciences

gowmatin@gmail.com+98 31 3668 7898

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026